


产品信息
| 名称 | SW626 (人卵巢癌细胞) (L15) (STR鉴定正确) (暂不出售) |
| 别称 | SW-626; SW 626 |
| 背景描述 | The SW 626 cell line was initiated by A. Leibovitz in January 1974 at the Scott and White Clinic, Temple, Texas from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian. Although originally thought to be of ovarian origin , a recent report has suggested that the SW 626 cell line might have been derived from an ovarian metastasis of a primary adenocarcinoma of the colon. |
| 种属 | 人类 |
| 年龄(性别) | 女性,46岁 |
| 组织来源 | 子宫内膜腺癌组织 |
| 生长特性 | 贴壁细胞 |
| 细胞形态 | 上皮细胞样 |
| 细胞类型 | 肿瘤细胞 |
| 肿瘤类型 | 卵巢癌细胞 |
| 生物安全等级 | 1 |
| 生长培养基 | Leibovitz's L-15+10% FBS+1% P/S |
| 推荐传代比例 | 1:2-1:4 |
| 推荐换液频率 | 2~3次/周 |
| 冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO温度:液氮 |
| 培养条件 | 气相:空气,100%温度:37℃ |
| 致瘤性 | Yes, in nude mice produces well differentiated papillary adenocarcinomas consistent with ovarian primary. |
| 注意事项 | 1、该细胞推荐使用Leibovitz's L-15培养基进行培养,Leibovitz's L-15不可以通入二氧化碳,会产生细胞毒性; 2、如您没有无二氧化碳的培养箱,可使用DMEM替代Leibovitz's L-15,使用DMEM培养基时即可正常通入5%二氧化碳; 3、配套专用培养基默认Leibovitz's L-15配置,如需DMEM配方,请联系销售下单备注更改。 |
| 保藏机构 | ATCC; HTB-78 ECACC; 91091203 |
STR位点信息
| Amelogenin | X |
| CSF1PO | 11 |
| D2S1338 | 25 |
| D3S1358 | 15,17 |
| D5S818 | 12 |
| D7S820 | 12 |
| D8S1179 | 11 |
| D13S317 | 11 |
| D16S539 | 11 |
| D18S51 | 14 |
| D19S433 | 14 |
| D21S11 | 27,29 |
| FGA | 21,23 |
| PentaD | 9,13 |
| PentaE | 7,11 |
| TH01 | 9.3 |
| TPOX | 8 |
| vWA | 17,18 |
| D1S1656 | 15,17.3 |
| D6S1043 | 11 |
| D12S391 | 18,23 |

您的报价需求已收到


